Alcohol-Related Liver Disease: GSK4532990 Study

We are investigating a new medication, GSK4532990, for adults with alcohol-related liver disease. The study aims to see if it is safe and effective compared to a placebo.

1-2 years11-15 visitsEfficacy phase (II)HepatologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Esbjerg Og Grindsted Sygehus
Research Unit of Medical Gastroenterology-Hepatology
Esbjerg, Denmark
Region Hovedstaden
Gastro Unit
Hvidovre, Denmark
Odense University Hospital
Department of Gastroenterology and Hepatology
Odense, Denmark

Sponsor: Glaxosmithkline Research & Development Limited
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.